These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11922775)

  • 1. Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles.
    Demers GW; Sugarman BJ; Beltran JC; Westreich LN; Ahmed CM; Lau JY; Hong Z; Lanford RE; Maneval DC
    Toxicol Appl Pharmacol; 2002 Apr; 180(1):36-42. PubMed ID: 11922775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers.
    Iqbal Ahmed CM; Johnson DE; Demers GW; Engler H; Howe JA; Wills KN; Wen SF; Shinoda J; Beltran J; Nodelman M; Machemer T; Maneval DC; Nagabhushan TL; Sugarman BJ
    Cancer Gene Ther; 2001 Oct; 8(10):788-95. PubMed ID: 11687902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: a study in rats evaluating dosing regimens.
    Connor RJ; Anderson JM; Machemer T; Maneval DC; Engler H
    Urology; 2005 Jul; 66(1):224-9. PubMed ID: 15992886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
    Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T
    J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo tumor suppression by adenovirus-mediated interferon alpha2b gene delivery.
    Ahmed CM; Sugarman BJ; Johnson DE; Bookstein RE; Saha DP; Nagabhushan TL; Wills KN
    Hum Gene Ther; 1999 Jan; 10(1):77-84. PubMed ID: 10022532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer.
    Nagabhushan TL; Maneval DC; Benedict WF; Wen SF; Ihnat PM; Engler H; Connor RJ
    Cytokine Growth Factor Rev; 2007; 18(5-6):389-94. PubMed ID: 17692556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus delivery provides extended interferon-alpha exposure and augments treatment of metastatic carcinoma.
    Brin E; Atencio I; Helmich BK; Maneval D; Laface D
    Cancer Gene Ther; 2006 Jul; 13(7):664-75. PubMed ID: 16514422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model.
    Tsai V; Johnson DE; Rahman A; Wen SF; LaFace D; Philopena J; Nery J; Zepeda M; Maneval DC; Demers GW; Ralston R
    Clin Cancer Res; 2004 Nov; 10(21):7199-206. PubMed ID: 15534093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice.
    Ahmed CM; Wills KN; Sugarman BJ; Johnson DE; Ramachandra M; Nagabhushan TL; Howe JA
    J Interferon Cytokine Res; 2001 Jun; 21(6):399-408. PubMed ID: 11440637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
    Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
    Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the immune response to permit ex vivo gene therapy for spine fusion with human type 5 adenoviral delivery of the LIM mineralization protein-1 cDNA.
    Kim HS; Viggeswarapu M; Boden SD; Liu Y; Hair GA; Louis-Ugbo J; Murakami H; Minamide A; Suh DY; Titus L
    Spine (Phila Pa 1976); 2003 Feb; 28(3):219-26. PubMed ID: 12567021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
    Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
    Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of human interferon-gamma via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity.
    Stoeckle MY; Falck-Pederson E; Rubin BY; Anderson SL; Murray HW
    J Interferon Cytokine Res; 1996 Dec; 16(12):1015-9. PubMed ID: 8974003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferon.
    Lee CH; Kim HW; Kim T; Lee SW
    Biochem Biophys Res Commun; 2015 Mar; 458(4):830-5. PubMed ID: 25689720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.
    Fiedler M; Rödicker F; Salucci V; Lu M; Aurisicchio L; Dahmen U; Jun L; Dirsch O; Pützer BM; Palombo F; Roggendorf M
    J Virol; 2004 Sep; 78(18):10111-21. PubMed ID: 15331744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth inhibition by interferon-alpha using PEGylated protein or adenovirus gene transfer with constitutive or regulated expression.
    Demers GW; Johnson DE; Machemer T; Looper LD; Batinica A; Beltran JC; Sugarman BJ; Howe JA
    Mol Ther; 2002 Jul; 6(1):50-6. PubMed ID: 12095303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
    Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
    Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition.
    Indraccolo S; Tisato V; Tosello V; Habeler W; Esposito G; Moserle L; Stievano L; Persano L; Chieco-Bianchi L; Amadori A
    Hum Gene Ther; 2005 Aug; 16(8):957-70. PubMed ID: 16076254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.